ARK Genomic (Switzerland) Volatility

ARKG Etf   4.38  0.03  0.68%   
At this stage we consider ARK Etf to be moderately volatile. ARK Genomic secures Sharpe Ratio (or Efficiency) of 0.0271, which signifies that the etf had a 0.0271 % return per unit of return volatility over the last 3 months. We have found thirty technical indicators for ARK Genomic, which you can use to evaluate the volatility of the entity. Please confirm ARK Genomic's Mean Deviation of 2.24, semi deviation of 2.49, and Risk Adjusted Performance of 0.0445 to double-check if the risk estimate we provide is consistent with the expected return of 0.0773%.
  
ARK Genomic Etf volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of ARK daily returns, and it is calculated using variance and standard deviation. We also use ARK's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of ARK Genomic volatility.
Downward market volatility can be a perfect environment for investors who play the long game with ARK Genomic. They may decide to buy additional shares of ARK Genomic at lower prices to lower the average cost per share, thereby improving their portfolio's performance when markets normalize.

ARK Genomic Market Sensitivity And Downside Risk

ARK Genomic's beta coefficient measures the volatility of ARK etf compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents ARK etf's returns against your selected market. In other words, ARK Genomic's beta of 0.57 provides an investor with an approximation of how much risk ARK Genomic etf can potentially add to one of your existing portfolios. ARK Genomic currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ARK Genomic's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ARK Genomic's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze ARK Genomic Demand Trend
Check current 90 days ARK Genomic correlation with market (Dow Jones Industrial)

ARK Beta

    
  0.57  
ARK standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  2.86  
It is essential to understand the difference between upside risk (as represented by ARK Genomic's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of ARK Genomic's daily returns or price. Since the actual investment returns on holding a position in ark etf tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in ARK Genomic.

ARK Genomic Etf Volatility Analysis

Volatility refers to the frequency at which ARK Genomic etf price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with ARK Genomic's price changes. Investors will then calculate the volatility of ARK Genomic's etf to predict their future moves. A etf that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A etf with relatively stable price changes has low volatility. A highly volatile etf is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of ARK Genomic's volatility:

Historical Volatility

This type of etf volatility measures ARK Genomic's fluctuations based on previous trends. It's commonly used to predict ARK Genomic's future behavior based on its past. However, it cannot conclusively determine the future direction of the etf.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for ARK Genomic's current market price. This means that the etf will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on ARK Genomic's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. The Median Price line plots median indexes of ARK Genomic price series.

ARK Genomic Projected Return Density Against Market

Assuming the 90 days trading horizon ARK Genomic has a beta of 0.5672 . This suggests as returns on the market go up, ARK Genomic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ARK Genomic will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ARK Genomic or ARK sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ARK Genomic's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ARK etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
ARK Genomic has an alpha of 0.0995, implying that it can generate a 0.0995 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
ARK Genomic's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how ark etf's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an ARK Genomic Price Volatility?

Several factors can influence a etf's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

ARK Genomic Etf Risk Measures

Assuming the 90 days trading horizon the coefficient of variation of ARK Genomic is 3694.98. The daily returns are distributed with a variance of 8.17 and standard deviation of 2.86. The mean deviation of ARK Genomic is currently at 2.22. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.7
α
Alpha over Dow Jones
0.1
β
Beta against Dow Jones0.57
σ
Overall volatility
2.86
Ir
Information ratio 0.02

ARK Genomic Etf Return Volatility

ARK Genomic historical daily return volatility represents how much of ARK Genomic etf's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The fund accepts 2.8579% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7161% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

ARK Genomic Investment Opportunity

ARK Genomic has a volatility of 2.86 and is 3.97 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of ARK Genomic is lower than 25 percent of all global equities and portfolios over the last 90 days. You can use ARK Genomic to protect your portfolios against small market fluctuations. The etf experiences a moderate downward daily trend and can be a good diversifier. Check odds of ARK Genomic to be traded at 4.29 in 90 days.

Average diversification

The correlation between ARK Genomic and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ARK Genomic and DJI in the same portfolio, assuming nothing else is changed.

ARK Genomic Additional Risk Indicators

The analysis of ARK Genomic's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in ARK Genomic's investment and either accepting that risk or mitigating it. Along with some common measures of ARK Genomic etf's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential etfs, we recommend comparing similar etfs with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

ARK Genomic Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against ARK Genomic as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. ARK Genomic's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, ARK Genomic's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to ARK Genomic.